Results 111 to 120 of about 15,175 (215)

Slowly progressive ischemic stroke as first manifestation of essential thrombocythemia.

open access: yes, 1989
We report a case of essential thrombocythemia, the only clinical manifestation of which consisted of neurologic symptoms, including anomic aphasia, tactile and painful hypesthesia in the right hand, headache, and Gerstmann syndrome, with a relatively ...
P Ricci   +4 more
core   +1 more source

ESSENTIAL THROMBOCYTHEMIA: ETIOPATHOGENESIS AND THERAPEUTICS

open access: yes, 2017
Trabalho de Projeto do Mestrado Integrado em Medicina apresentado à Faculdade de MedicinaA trombocitémia essencial (TE) é uma neoplasia mieloproliferativa que resulta da proliferação clonal de progenitores hematopoiéticos da linhagem megacariocítica ...
Castilho, Bruno Eduardo de Miranda
core  

Pericardial Hemorrhage Due to Acetylsalicylic Acid in a Patient With Essential Thrombocythemia

open access: yes, 2009
Essential thrombocythemia is a clonal myeloproliferative disorder that Causes thrombocytosis. Essential thrombocythemia is characterized by increased incidence of thrombosis with arterial event more than venous events and hemorrhagic complications ...
Yazici, Mehmet   +5 more
core   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

open access: yes, 2014
Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticulin gene (CALR) mutation. We studied biologic and clinical features of essential thrombocythemia according to JAK2 or CALR mutation status and in relation ...
Pietra, D   +19 more
core   +1 more source

Pseudo-acquired vWD in essential thrombocythemia: the role of platelets

open access: yes, 2014
Essential Thrombocythemia affects von Willebrand ...
Lancellotti, Stefano   +4 more
core  

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

open access: yes
Background: We conducted a randomized comparison of hydroxyurea with anagrelide in the treatment of essential thrombocythemia. Methods: A total of 809 patients with essential thrombocythemia who were at high risk for vascular events received low-dose ...
Revell P   +13 more
core  

Essential thrombocythemia as underlying cause of malabsorption syndrome.

open access: yes, 2010
Essential thrombocythemia as underlying cause of malabsorption ...
Teofili, Luciana   +6 more
core  

Home - About - Disclaimer - Privacy